Usage patterns of over-the-counter phenazopyridine (pyridium)
- PMID: 12709095
- PMCID: PMC1494847
- DOI: 10.1046/j.1525-1497.2003.20709.x
Usage patterns of over-the-counter phenazopyridine (pyridium)
Abstract
Objectives: Little is known about how the public uses formerly prescription medications that are available over-the-counter (OTC). This study examines whether consumers inappropriately use and substitute a recently widely distributed OTC urinary analgesic, phenazopyridine, for provider care.
Design/setting: We conducted a cross-sectional survey of a stratified cluster random sample of OTC phenazopyridine purchasers (N = 434) in 31 Los Angeles retail pharmacies over 5 months. Recruited by shelf advertisements, participants were 18 years or older who purchased a phenazopyridine product. Each completed a 25-item self-administered anonymous questionnaire. Inappropriate use was defined as 1) having medical contraindications to phenazopyridine, or 2) not having concurrent antibiotic and/or provider evaluation for the urinary symptoms.
Results: The survey response rate was 58%. Fifty-one percent of the respondents used OTC phenazopyridine inappropriately, and 38% substituted it for medical care. Multiple logistic regression analyses revealed that inappropriate use was correlated with having little time to see a provider (odds ratio [OR], 1.57; 95% confidence interval [95% CI], 1.26 to 1.96), receiving friend's or family's advice (OR, 1.25; 95% CI, 1.05 to 1.47), having prior urinary tract infections (OR, 0.49; 95% CI, 0.30 to 0.80), having used prescription phenazopyridine, (OR, 0.40; 95% CI, 0.25 to 0.63), and having back pain (OR, 0.34; 95% CI, 0.16 to 0.74). Similar correlates were found in those who substituted OTC phenazopyridine for provider care. Respondents with incorrect knowledge about phenazopyridine's mode of action had 1.9 times greater odds of inappropriate use and 2.2 times greater odds of substitution than those who had correct knowledge about this drug.
Conclusion: Inappropriate use of OTC phenazopyridine appears common. Increasing the public's knowledge about reclassified drugs may help to mitigate this problem.
Comment in
-
Pharma's bad karma. Resistance is not futile.J Gen Intern Med. 2003 Apr;18(4):315-6. doi: 10.1046/j.1525-1497.2003.30290.x. J Gen Intern Med. 2003. PMID: 12709101 Free PMC article. No abstract available.
Similar articles
-
Consumer knowledge of over-the-counter phenazopyridine.Ann Fam Med. 2004 May-Jun;2(3):240-4. doi: 10.1370/afm.61. Ann Fam Med. 2004. PMID: 15209201 Free PMC article.
-
Consumer usage patterns of nonprescription histamine2-receptor antagonists.Am J Gastroenterol. 2004 Apr;99(4):606-10. doi: 10.1111/j.1572-0241.2004.04130.x. Am J Gastroenterol. 2004. PMID: 15089889
-
Self-medication with over the counter drugs, prevalence of risky practice and its associated factors in pharmacy outlets of Asmara, Eritrea.BMC Public Health. 2019 Feb 6;19(1):159. doi: 10.1186/s12889-019-6470-5. BMC Public Health. 2019. PMID: 30727984 Free PMC article.
-
Over-the-counter analgesics in older adults: a call for improved labelling and consumer education.Drugs Aging. 2004;21(8):485-98. doi: 10.2165/00002512-200421080-00001. Drugs Aging. 2004. PMID: 15182214 Review.
-
Phenazopyridine in urinary tract infections.Ann Pharmacother. 1996 Jul-Aug;30(7-8):866-8. doi: 10.1177/106002809603000727. Ann Pharmacother. 1996. PMID: 8826573 Review. No abstract available.
Cited by
-
Heinz body hemolysis following extended use phenazopyridine in a post-HCT patient with hemorrhagic cystitis: An old problem for a new generation.Clin Case Rep. 2023 Mar 7;11(3):e7012. doi: 10.1002/ccr3.7012. eCollection 2023 Mar. Clin Case Rep. 2023. PMID: 36911643 Free PMC article.
-
Pharma's bad karma. Resistance is not futile.J Gen Intern Med. 2003 Apr;18(4):315-6. doi: 10.1046/j.1525-1497.2003.30290.x. J Gen Intern Med. 2003. PMID: 12709101 Free PMC article. No abstract available.
-
Implications of a switch from prescription to over-the-counter status for allergy drugs.Curr Allergy Asthma Rep. 2004 May;4(3):245-50. doi: 10.1007/s11882-004-0033-1. Curr Allergy Asthma Rep. 2004. PMID: 15056408 Review.
References
-
- Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med. 2001;345:810–6. - PubMed
-
- Jacob LR. Prescription to over-the-counter drug reclassification. Am Fam Physician. 1998;57:2209–14. - PubMed
-
- Snyder K. Marketing consumer trends driving switch-hitters up: prescription drugs changing to over-the-counter status. Drug Topics. 1997;89:141.
-
- Synder K. Rising tide—New wave of Rx-to-OTC switches coming. Drug Topics. 1995;207:47–9.
-
- Rosenau PV. Rx to OTC switch movement. Med Care Rev. 1994;51:429–66. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical